Publications by authors named "Rae Staben"
Article Synopsis
- The study aimed to test if using a patient’s CYP2D6 genotype to guide metoprolol dosing could lower the risk of developing postoperative atrial fibrillation (AF) after cardiac surgery.
- The trial involved 73 cardiac surgery patients, who were categorized based on their CYP2D6 metabolizer status to inform medication dosing.
- Results showed that 30% of the patients developed postoperative AF, and there was no significant evidence that adjusting metoprolol based on metabolizer status effectively reduced this risk.